Analytical validation of a plasma-based cfDNA NGS assay (Guardant360 Liquid CDx) for comprehensive solid tumor profiling.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Brett Kennedy, Xianxian Liu, Jessica Kurata, Ankit Jambusaria, Krishnalekha Datta, Karen Ryall, Nageswara Alla, Raghu Chandramohan, Gowtham Jayakumaran, Claire Olson, Pooja Bhat, Paul Spurgeon, Sophie Weiss, Priyanka Lakkaraju, Kevin Doubleday, Tianran Jia, Sammy Rantisi, Soni Shukla, Darya I. Chudova
Institution: Guardant (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162485274
Cites:
Cited by:
Related to: